Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9651 USD | -5.38% | -18.90% | -31.06% |
09/05 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
09/05 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
154M | - | |||||
109B | ||||||
105B | ||||||
22.25B | - | |||||
22.09B | - | |||||
18.68B |